Bankers may be starting the Valentine’s Weekend early after navigating a rocky stock market this week and pricing 16 deals – mostly SPACs plus a sprinkling of small-cap IPOs and uplistings – to raise about $1.24 billion. The week’s mix included a public offering after an uplisting. (This column, initially published on Monday, Feb. 7, […]
February 7, 2022 Read MoreArcellx (ACLX), a cancer-focused biotech, shot up to $19 at its opening trade on Friday (Feb. 4, 2022) – up $4 from its IPO price – in its NASDAQ debut. Arcellx priced its IPO on Thursday (Feb. 3, 2022) at $15 – the low end of its $15-to-$17 range – on 8.25 million shares. The […]
January 31, 2022 Read MoreCredo Technology Group Holding, Ltd. (CRDO) slashed the number of shares in its IPO and priced the deal at $10 – the low end of its $10-to-$12 range – on Wednesday night (Jan. 26, 2022). The deal was cut to 20 million shares, down from 25 million in the prospectus, to raise $200 million – […]
January 27, 2022 Read MoreCredo Technology Group Holding Ltd. (CRDO proposed), a semiconductor connectivity solutions provider, is the name to note as January 2022 enters its final week. Credo is the only large deal on this week’s IPO Calendar – in a market frozen by fear of rising interest rates ahead and inflation at a 40-year high. The NASDAQ […]
January 23, 2022 Read MorePostponed is the word of the day. Bitcoin miner Rhodium Enterprises, Inc. (RHDM proposed) and a REIT, Four Springs Capital Trust (FSPR proposed), have pulled their IPOs – both expected to start trading today (Thursday, Jan. 20, 2022) – “due to market conditions.” The NASDAQ’s slide into correction territory on Wednesday was the reason. “They […]
January 20, 2022 Read MoreJapan, a Bitcoin miner and a real estate investment trust (REIT) are featured on this week’s IPO Calendar. But the U.S. stock market’s plunge on Tuesday drove the NASDAQ down close to correction territory as bond yields hit a two-year high. Tuesday’s sell-off was a shock after the long holiday weekend. The U.S. stock market […]
January 17, 2022 Read MorePrivate equity powerhouse TPG, Inc. (TPG) jumped 15.25 percent on Thursday (Jan. 13, 2022) in its NASDAQ debut – to close at $34, up $4.50 from its $29.50 IPO price – and you could almost catch the sweet scent of relief washing over Wall Street after a nerve-wracking week. TPG priced its IPO at the mid-point […]
January 11, 2022 Read MoreBiotechs braved the chill winds of January to jump-start the 2022 IPO Calendar. Two of the week’s three biotech IPOs – Amylyx Pharmaceuticals (AMLX) and CinCor Pharma (CINC) – upsized their IPOs by adding more shares and pricing their deals at the mid-point of their ranges. The third biotech IPO – Vigil Neuroscience, Inc. (VIGL) – […]
January 7, 2022 Read MoreWe wish a very Merry Christmas to all of our IPOScoop readers and subscribers who are celebrating! Happy Holidays to all! No traditional IPOs are confirmed for the pricing schedule next week. It’s likely, though, that a few small-cap IPOs and a steady run of SPACs will be on tap. The IPO market traditionally slows […]
December 25, 2021 Read MoreSamsara, Inc. (IOT) priced its long-awaited IPO at $23 – the top of its $20-to-$23 range – and sold 35 million shares on Tuesday night (Dec. 14, 2021). The IPO, dubbed “the deal of the week,” raised $805 million. Samsara’s IPO was the standout on a busy night for IPO bankers, who raised a whopping […]
December 15, 2021 Read More